Logo

American Heart Association

  52
  0


Final ID: Su3095

Phenotypic Age Predicts Long-Term Cardiac Outcomes Better Than Chronological Age in Patients with Acute Myocardial Infarction

Abstract Body (Do not enter title and authors here): Background: Phenotypic Age (PhenoAge), which is calculated based on chronological age and nine biomarkers, has been shown to better predict in-hospital outcomes in patients with acute myocardial infarction (AMI).
Research Question: This study aimed to determine whether PhenoAge predicts long-term cardiac outcomes in AMI patients more accurately than chronological age.
Methods: In this retrospective study, we included 5,440 patients who underwent percutaneous coronary intervention (PCI) for AMI at a tertiary hospital between December 2009 and November 2018. Clinical outcomes included cardiac death (defined as death due to heart failure, myocardial infarction, or arrhythmia) and all-cause death.
Results: The mean PhenoAge and chronological age of the entire patient cohort were 66.24 ± 11.77 years and 78.55 ± 19.07 years, respectively. During a follow-up period of 51.03 ± 36.97 months, there were 331 cases of cardiac death and 570 cases of all-cause death. The area under the curve (AUC) of the receiver operating characteristic (ROC) curve for predicting cardiac death was higher for PhenoAge (AUC: 0.746, p < 0.01) than for chronological age (AUC: 0.638, p < 0.01). Similarly, for all-cause death, PhenoAge (AUC: 0.719, p < 0.01) outperformed chronological age (AUC: 0.649, p < 0.01). However, both PhenoAge (AUC: 0.436, p < 0.01) and chronological age (AUC: 0.455, p < 0.01) showed low predictive power for revascularization. Patients with PhenoAge ≥80 had a higher risk of cardiac death than those with PhenoAge <80 [hazard ratio (HR) 5.12; 95% confidence interval (CI) 3.97–6.59; p < 0.01], and this risk was greater than that observed in patients with chronological age ≥80 compared to those <80 (HR 3.39; CI 2.66–4.34; p < 0.01).
Conclusion: PhenoAge more accurately predicts long-term outcomes, including cardiac death, than chronological age in AMI patients who underwent PCI. The risk of cardiac death in patients with PhenoAge ≥80 is higher than in those with PhenoAge <80 and exceeds the corresponding risk difference observed using chronological age.
  • Lee, Hyo Jin  ( Gyeongsang National University School of Medicine , Jinju , Korea (the Republic of) )
  • Author Disclosures:
    Hyo Jin Lee: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Next-Generation Biomarkers & Omics-Driven Risk Stratification

Sunday, 11/09/2025 , 03:15PM - 04:15PM

Abstract Poster Board Session

More abstracts on this topic:
A novel method for measuring HDL-bound unconjugated bilirubin using an eel fluorescent protein reveals its association with reduced coronary artery disease

Fujioka Tomoo, Iino Takuya, Toh Ryuji, Harada Amane, Nagao Manabu, Shinohara Masakazu, Ishida Tatsuro, Otake Hiromasa

Admission Cell-free DNA Predicts Cardiogenic Shock Progression and In-Hospital Mortality

Park Ashley, Kong Hyesik, Andargie Temesgen, Jang Moon, Solomon Michael, Brusca Samuel, Barnett Christopher, Obrien Connor, Agbor-enoh Sean

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available